Galventa
Michael has studied chemistry and biology with a Ph.D. from ETH Zurich. He has significant experience from previous R&D roles at leading industrial Life Science organisations in metabolic and cardiovascular health.A serial entrepreneur, Michael has led several start-up companies to profitability, including Siegfried Biologics, Kuros Biosciences and ChromaCon. Besides his assignment with Galventa, Michael is engaged in helping a Venture boutique company, Remora Capital to launch new start-up companies in the field of Cancer/Immunology and Healthy Aging.
This person is not in any teams
This person is not in any offices
Galventa
Galventa compound with a release pattern based on micro pellets for use in the relieve of sleep inertia symptoms.